Showing results (121-130 of 144) with videos related to
Sort By:
Pageof 15
Journal of Crohn'S & Colitis|August 12, 2025
Longitudinal Profiles of Fecal Calprotectin and C-Reactive Protein in Relation to Outcomes in Crohn's Disease Patients on InfliximabFernando Magro, Beatriz Domingues, Maria Manuela Estevinho, et al.Journal of Crohn'S & Colitis|January 20, 2024
The Influence of Subclinical Active Inflammation on IFX Pharmacokinetic Modeling and Disease Progression Assessment: Findings from a Prospective Real-World Study in Inflammatory Bowel Disease PatientsFernando Magro, Samuel Fernandes, Marta Patita, et al.Human Mutation|July 29, 2018
LAMA2 gene mutation update: Toward a more comprehensive picture of the laminin-α2 variome and its related phenotypesJorge Oliveira, Angela Gruber, Márcio Cardoso, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 13, 2021
Subclinical Persistent Inflammation as Risk Factor for Crohn's Disease Progression: Findings From a Prospective Real-World Study of 2 YearsFernando Magro, Diogo Magalhães, Marta Patita, et al.Virus Genes|May 17, 2023
Molecular characterization of Brazilian FeLV strains in São Luis, Maranhão BrazilNathálya Dos Santos Martins, Ana Paula Sousa Rodrigues, Juliana Marques Bicalho, et al.Journal of the Neurological Sciences|August 15, 2024
Prognostic factors associated with disability in a cohort of neuromyelitis optica spectrum disorder and MOG-associated disease from a nationwide Portuguese registryJoão Moura, Raquel Samões, Ana Paula Sousa, et al.Evidence-Based Complementary and Alternative Medicine : Ecam|November 7, 2013
Strychnos pseudoquina and Its Purified Compounds Present an Effective In Vitro Antileishmanial ActivityPaula Sousa Lage, Pedro Henrique Rocha de Andrade, Amanda de Santana Lopes, et al.Ebiomedicine|June 21, 2017
Calprotectin and the Magnitude of Antibodies to Infliximab in Clinically-stable Ulcerative Colitis Patients are More Relevant Than Infliximab Trough Levels and Pharmacokinetics for Therapeutic EscalationFernando Magro, Joana Afonso, Susana Lopes, et al.United European Gastroenterology Journal|June 15, 2023
How many biomarker measurements are needed to predict prognosis in Crohn's disease patients under infliximab?-A prospective studyFernando Magro, Maria Manuela Estevinho, Gaia Catalano, et al.Environmental Research|December 13, 2021
Mercury spatiality and mobilization in roadside soils adjacent to a savannah ecological reserveYgor O S Rodrigues, José G Dórea, P M B Landim, et al.Pageof 15